These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 18374694)
1. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Muntner P; Winston J; Uribarri J; Mann D; Fox CS Am J Med; 2008 Apr; 121(4):341-8. PubMed ID: 18374694 [TBL] [Abstract][Full Text] [Related]
2. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Foster MC; Hwang SJ; Larson MG; Lichtman JH; Parikh NI; Vasan RS; Levy D; Fox CS Am J Kidney Dis; 2008 Jul; 52(1):39-48. PubMed ID: 18440684 [TBL] [Abstract][Full Text] [Related]
3. Relationship between body mass index and high cystatin levels among US adults. Shankar A; Teppala S J Clin Hypertens (Greenwich); 2011 Dec; 13(12):925-30. PubMed ID: 22142352 [TBL] [Abstract][Full Text] [Related]
4. Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease. Sabanayagam C; Wong TY; Liao J; Sethi S; Teo BW Clin Exp Nephrol; 2014 Dec; 18(6):919-24. PubMed ID: 24526413 [TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Köttgen A; Selvin E; Stevens LA; Levey AS; Van Lente F; Coresh J Am J Kidney Dis; 2008 Mar; 51(3):385-94. PubMed ID: 18295054 [TBL] [Abstract][Full Text] [Related]
6. Serum cystatin C and prediabetes in non-obese US adults. Sabanayagam C; Wong TY; Xiao J; Shankar A Eur J Epidemiol; 2013 Apr; 28(4):311-6. PubMed ID: 23417728 [TBL] [Abstract][Full Text] [Related]
7. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. Muntner P; Mann D; Winston J; Bansilal S; Farkouh ME Am J Cardiol; 2008 Jul; 102(1):54-7. PubMed ID: 18572035 [TBL] [Abstract][Full Text] [Related]
8. Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. LaCroix AZ; Lee JS; Wu L; Cauley JA; Shlipak MG; Ott SM; Robbins J; Curb JD; Leboff M; Bauer DC; Jackson RD; Kooperberg CL; Cummings SR; J Am Geriatr Soc; 2008 Aug; 56(8):1434-41. PubMed ID: 18662213 [TBL] [Abstract][Full Text] [Related]
9. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Nguyen S; McCulloch C; Brakeman P; Portale A; Hsu CY Pediatrics; 2008 Jan; 121(1):37-45. PubMed ID: 18166555 [TBL] [Abstract][Full Text] [Related]
10. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study. Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG; Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491 [TBL] [Abstract][Full Text] [Related]
11. Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney disease. Shankar A; Teppala S J Am Soc Hypertens; 2011; 5(5):378-84. PubMed ID: 21498146 [TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA). Moran A; Katz R; Jenny NS; Astor B; Bluemke DA; Lima JA; Siscovick D; Bertoni AG; Shlipak MG Am J Kidney Dis; 2008 Nov; 52(5):839-48. PubMed ID: 18845370 [TBL] [Abstract][Full Text] [Related]
13. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413 [TBL] [Abstract][Full Text] [Related]
14. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives. Satirapoj B; Supasyndh O; Mayteedol N; Punpanich D; Chaiprasert A; Nata N; Ruangkanchanasetr P; Kanjanakul I; Choovichian P Nephrology (Carlton); 2013 Mar; 18(3):229-34. PubMed ID: 23279639 [TBL] [Abstract][Full Text] [Related]
15. Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. Nguyen XM; Lane J; Smith BR; Nguyen NT J Gastrointest Surg; 2009 Jul; 13(7):1205-12. PubMed ID: 19415399 [TBL] [Abstract][Full Text] [Related]
16. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. Samartzis D; Karppinen J; Mok F; Fong DY; Luk KD; Cheung KM J Bone Joint Surg Am; 2011 Apr; 93(7):662-70. PubMed ID: 21471420 [TBL] [Abstract][Full Text] [Related]
17. Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010. Juraschek SP; Miller ER; Gelber AC Arthritis Care Res (Hoboken); 2013 Jan; 65(1):127-32. PubMed ID: 22778033 [TBL] [Abstract][Full Text] [Related]
18. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Stevens LA; Coresh J; Schmid CH; Feldman HI; Froissart M; Kusek J; Rossert J; Van Lente F; Bruce RD; Zhang YL; Greene T; Levey AS Am J Kidney Dis; 2008 Mar; 51(3):395-406. PubMed ID: 18295055 [TBL] [Abstract][Full Text] [Related]
19. Cystatin C and risk of heart failure in the Physicians' Health Study (PHS). Djoussé L; Kurth T; Gaziano JM Am Heart J; 2008 Jan; 155(1):82-6. PubMed ID: 18082494 [TBL] [Abstract][Full Text] [Related]
20. Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study. Peralta CA; Whooley MA; Ix JH; Shlipak MG Am J Hypertens; 2006 Sep; 19(9):939-46. PubMed ID: 16942937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]